name:-0.17472290992737
name:-0.13073205947876
name:-0.040186882019043
ASTEX THERAPEUTICS LIMITED Patent Filings

ASTEX THERAPEUTICS LIMITED

Patent Applications and Registrations

Patent applications and USPTO patent grants for ASTEX THERAPEUTICS LIMITED.The latest application filed is for "bicyclic heterocycle compounds and their uses in therapy".

Company Profile
46.165.200
  • ASTEX THERAPEUTICS LIMITED - Cambridge GB
  • ASTEX THERAPEUTICS LTD - Cambridge GB
  • Astex Therapeutics Ltd. - Cambridge GB
  • ASTEX THERAPEUTICS LIMITED - Cambridge, Cambridgeshire GB
  • ASTEX THERAPEUTICS LIMITED - Cambridge, Cambridges GB
  • Astex Therapeutics, Limited - Cambridgeshire N/A GB
  • Astex Therapeutics, Ltd - Milton Road, Cambridge N/A GB
  • Astex Therapeutics, Limited - Milton Road, Cambridge GB
  • ASTEX THERAPEUTICS LTD - Cambridge, Cambridgeshire GB
  • Astex Therapeutics, Ltd. - Milton Road, Cambridge GB
  • Astex Therapeutics Limited - Cambrdige GB
  • Astex Therapeutics LTD - Cambridgeshire GB
  • ASTEX THERAPEUTICS LIMITED; - US
  • ASTEX THERAPEUTICS, LTD. - Cambrige UK
  • ASTEX THERAPEUTICS LIMITED - 436 Cambridge Science Park Milton Road Cambridge UK
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Bicyclic Heterocycle Compounds And Their Uses In Therapy
App 20220204503 - CHESSARI; Gianni ;   et al.
2022-06-30
Pyrazolyl Quinoxaline Kinase Inhibitors
App 20220135544 - SAXTY; Gordon ;   et al.
2022-05-05
Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity
App 20220106287 - CHESSARI; Gianni ;   et al.
2022-04-07
Ether Linked Triazoles As Nrf2 Activators
App 20220089590 - Cooper; Anthony William James ;   et al.
2022-03-24
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
Grant 11,261,171 - Chessari , et al. March 1, 2
2022-03-01
Combination of isoindolinone derivatives with SGI-110
Grant 11,236,047 - Chessari , et al. February 1, 2
2022-02-01
Bicyclic heterocycle compounds and their uses in therapy
Grant 11,225,476 - Chessari , et al. January 18, 2
2022-01-18
Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity
App 20210276984 - CHESSARI; Gianni ;   et al.
2021-09-09
Pyrrolopyrimidine Compounds And Their Uses
App 20210253578 - BESONG; Gilbert ;   et al.
2021-08-19
Chemical Compounds
App 20210238162 - CADILLA; Rodolfo ;   et al.
2021-08-05
Ether linked triazoles as NRF2 activators
Grant 11,059,816 - Cooper , et al. July 13, 2
2021-07-13
Pharmaceutical Compositions Comprising N-(3,5-dimethoxyphenyl)-n'-(1-methylethyl)-n-[3-(1-methyl-1h-pyrazol-4-yl- )quinoxalin-6-yl]ethane-1,2-diamine
App 20210169877 - BROGGINI; Diego Fernando Domenico
2021-06-10
Bicyclic Heterocycle Compounds And Their Uses In Therapy
App 20210122749 - WOOLFORD; Alison Jo-Anne ;   et al.
2021-04-29
Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
Grant 10,981,898 - Chessari , et al. April 20, 2
2021-04-20
Isoindolinone Inhibitors Of The Mdm2-p53 Interaction And Process For Making Them
App 20210101887 - HOWARD; Steven ;   et al.
2021-04-08
Combinations
App 20210038598 - JOVCHEVA; Eleonora ;   et al.
2021-02-11
Pharmaceutical compositions comprising N-(3,5-dimethoxyphenyl)-N'-1 methylethyl)-N-[3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-di- amine
Grant 10,898,482 - Broggini January 26, 2
2021-01-26
Bicyclic Heterocycle Compounds And Their Uses In Therapy
App 20200325134 - CHESSARI; Gianni ;   et al.
2020-10-15
Combinations of an FGFR inhibitor and an IGF1R inhibitor
Grant 10,736,900 - Jovcheva , et al. A
2020-08-11
Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity
App 20200247789A2 -
2020-08-06
Combinations
Grant 10,716,787 - Jovcheva , et al.
2020-07-21
Combination Of Isoindolinone Derivatives With Sgi-110
App 20200207711 - CHESSARI; Gianni ;   et al.
2020-07-02
Pyrazolyl Quinoxaline Kinase Inhibitors
App 20200131153 - SAXTY; Gordon ;   et al.
2020-04-30
Bicyclic heterocycle compounds and their uses in therapy
Grant 10,618,895 - Chessari , et al.
2020-04-14
Fgfr/pd-1 Combination Therapy For The Treatment Of Cancer
App 20200108141 - KARKERA; Jayaprakash ;   et al.
2020-04-09
Nrf2 regulators
Grant 10,604,509 - Kerns , et al.
2020-03-31
Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity
App 20200079761 - CHESSARI; Gianni ;   et al.
2020-03-12
Nrf2 REGULATORS
App 20200079759 - KERNS; Jeffrey K. ;   et al.
2020-03-12
N-aryl Pyrazoles As Nrf2 Regulators
App 20200071310 - BUDZIK; Brian W. ;   et al.
2020-03-05
Ether Linked Triazoles As Nrf2 Activators
App 20200071317 - COOPER; Anthony William James ;   et al.
2020-03-05
Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
Grant 10,544,132 - Chessari , et al. Ja
2020-01-28
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
Grant 10,526,311 - Chessari , et al. J
2020-01-07
Pyrazolyl quinoxaline kinase inhibitors
Grant 10,519,137 - Saxty , et al. Dec
2019-12-31
Bicyclic Heterocycle Compounds And Their Uses In Therapy
App 20190375748 - WOOLFORD; Alison Jo-Anne ;   et al.
2019-12-12
Nrf2 regulators
Grant 10,485,806 - Kerns , et al. Nov
2019-11-26
FGFR/PD-1 combination therapy for the treatment of cancer
Grant 10,478,494 - Karkera , et al. Nov
2019-11-19
Quinoxaline derivatives useful as FGFR kinase modulators
Grant 10,421,747 - Vermeulen , et al. Sept
2019-09-24
Biaryl pyrazoles as NRF2 regulators
Grant 10,364,256 - Callahan , et al.
2019-07-30
Nrf2 REGULATORS
App 20190224212 - Kerns; Jeffrey K. ;   et al.
2019-07-25
Arylcyclohexyl pyrazoles as NRF2 regulators
Grant 10,351,530 - Callahan , et al. July 16, 2
2019-07-16
Pteridines as FGFR inhibitors
Grant 10,272,087 - Saxty , et al.
2019-04-30
NRF2 regulators
Grant 10,272,095 - Kerns , et al.
2019-04-30
Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity
App 20190055215 - CHESSARI; Gianni ;   et al.
2019-02-21
Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity
App 20190016708 - CHESSARI; Gianni ;   et al.
2019-01-17
NRF2 Regulators
App 20190002454 - BOEHM; Jeffrey Charles ;   et al.
2019-01-03
Nrf2 regulators
Grant 10,144,731 - Davies , et al. De
2018-12-04
Combinations
App 20180296558 - JOVCHEVA; Eleonora ;   et al.
2018-10-18
Arylcyclohexyl Pyrazoles As Nrf2 Regulators
App 20180282283 - CALLAHAN; James ;   et al.
2018-10-04
Biaryl Pyrazoles As Nrf2 Regulators
App 20180282349 - CALLAHAN; James ;   et al.
2018-10-04
Combinations
Grant 10,085,982 - Jovcheva , et al. October 2, 2
2018-10-02
Substituted quinoxalines as FGFR kinase inhibitors
Grant 10,052,320 - Woodhead , et al. August 21, 2
2018-08-21
Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors
Grant 10,045,982 - Berdini , et al. August 14, 2
2018-08-14
Quinolines as FGFR kinase modulators
Grant 10,039,759 - Berdini , et al. August 7, 2
2018-08-07
Quinoxaline Derivatives Useful As Fgfr Kinase Modulators
App 20180186775 - VERMEULEN; Wim ;   et al.
2018-07-05
Nrf2 REGULATORS
App 20180179167 - KERNS; Jeffrey K. ;   et al.
2018-06-28
Nrf2 REGULATORS
App 20180179187 - KERNS; Jeffrey K. ;   et al.
2018-06-28
Nrf2 REGULATORS
App 20180169110 - KERNS; Jeffrey K. ;   et al.
2018-06-21
Pyrrolopyrimidine Compounds And Their Uses
App 20180155351 - Besong; Gilbert ;   et al.
2018-06-07
Bicyclic heterocycle compounds and their uses in therapy
Grant 9,980,973 - Chessari , et al. May 29, 2
2018-05-29
Pyrazolyl Quinoxaline Kinase Inhibitors
App 20180127397 - SAXTY; Gordon ;   et al.
2018-05-10
Hydroxybenzamide derivatives and their use as inhibitors of HSP90
Grant 9,914,719 - Chessari , et al. March 13, 2
2018-03-13
Bicyclic Heterocycle Compounds And Their Uses In Therapy
App 20180065959 - CHESSARI; Gianni ;   et al.
2018-03-08
Quinoxaline derivatives useful as FGFR kinase modulators
Grant 9,902,714 - Vermeulen , et al. February 27, 2
2018-02-27
Pharmaceutical Compositions Comprising N-(3,5-dimethoxyphenyl)-n'-(1-methylethyl)-n-[3-(1-methyl-1h-pyrazol-4-yl- )quinoxalin-6-yl]ethane-1,2-diamine
App 20180021332 - BROGGINI; Diego Fernando Domenico
2018-01-25
Substituted quinoxalines as FGFR kinase inhibitors
Grant 9,856,236 - Saxty , et al. January 2, 2
2018-01-02
Pyrazolyl quinoxaline kinase inhibitors
Grant 9,850,228 - Saxty , et al. December 26, 2
2017-12-26
Bicyclic Heterocycle Compounds And Their Uses In Therapy
App 20170334907 - WOOLFORD; Alison Jo-Anne ;   et al.
2017-11-23
Bicyclic heterocycle compounds and their uses in therapy
Grant 9,783,538 - Chessari , et al. October 10, 2
2017-10-10
Naphthyridine derivative compounds
Grant 9,757,364 - Angibaud , et al. September 12, 2
2017-09-12
Compounds
Grant 9,737,544 - Angibaud , et al. August 22, 2
2017-08-22
Pharmaceutical compounds
Grant 9,730,912 - Thompson August 15, 2
2017-08-15
Bicyclic Heterocycle Compounds And Their Uses In Therapy
App 20170224705 - CHESSARI; Gianni ;   et al.
2017-08-10
Bicyclic heterocycle compounds and their uses in therapy
Grant 9,676,768 - Woolford , et al. June 13, 2
2017-06-13
Bicyclic heterocycle compounds and their uses in therapy
Grant 9,663,512 - Chessari , et al. May 30, 2
2017-05-30
Combinations
App 20170119763 - JOVCHEVA; Eleonora ;   et al.
2017-05-04
New Compounds
App 20170105978 - ANGIBAUD; Patrick Rene ;   et al.
2017-04-20
Quinoxaline Derivatives Useful As Fgfr Kinase Modulators
App 20170101396 - VERMEULEN; Wim ;   et al.
2017-04-13
Combinations Of An Fgfr Inhibitor And An Igf1r Inhibitor
App 20170100406 - JOVCHEVA; Eleonora ;   et al.
2017-04-13
Bicyclic heterocycle compounds and their uses in therapy
Grant 9,617,283 - Chessari , et al. April 11, 2
2017-04-11
Bicyclic heterocycle compounds and their uses in therapy
Grant 9,617,248 - Chessari , et al. April 11, 2
2017-04-11
Bicyclic Heterocycle Compounds And Their Uses In Therapy
App 20170029419 - CHESSARI; Gianni ;   et al.
2017-02-02
Pteridines As Fgfr Inhibitors
App 20170000796 - SAXTY; Gordon ;   et al.
2017-01-05
Quinolines As Fgfr Kinase Modulators
App 20170000781 - BERDINI; Valerio ;   et al.
2017-01-05
Naphthyridine derivative compounds
Grant 9,527,844 - Angibaud , et al. December 27, 2
2016-12-27
Quinazolinone derivatives useful as FGFR kinase modulators
Grant 9,493,426 - Angibaud , et al. November 15, 2
2016-11-15
Nrf2 Regulators
App 20160318917 - Boehm; Jeffrey Charles ;   et al.
2016-11-03
Pyrazolyl Quinoxaline Kinase Inhibitors
App 20160311800 - SAXTY; Gordon ;   et al.
2016-10-27
Pyrazolyl quinoxaline kinase inhibitors
Grant 9,464,071 - Saxty , et al. October 11, 2
2016-10-11
Bicyclic heterocycle compounds and their uses in therapy
Grant 9,458,158 - Buck , et al. October 4, 2
2016-10-04
Pteridines as FGFR inhibitors
Grant 9,447,098 - Saxty , et al. September 20, 2
2016-09-20
Quinolines as FGFR kinase modulators
Grant 9,439,896 - Berdini , et al. September 13, 2
2016-09-13
Pyrazole Derivatives As Protein Kinase Modulators
App 20160250187 - BERDINI; Valerio ;   et al.
2016-09-01
SUBSTITUTED PYRIDO[2,3-b]PYRAZINES AS FGFR KINASE INHIBITORS
App 20160235744 - BERDINI; Valerio ;   et al.
2016-08-18
Pyrrolopyrimidine compounds and their uses
Grant 9,416,136 - Besong , et al. August 16, 2
2016-08-16
Substitutued Quinoxalines As Fgfr Kinase Inhibitors
App 20160220564 - WOODHEAD; Steven John ;   et al.
2016-08-04
New Compounds
App 20160213677 - ANGIBAUD; Patrick Rene ;   et al.
2016-07-28
Naphthyridine Derivative Compounds
App 20160108034 - ANGIBAUD; Patrick Rene ;   et al.
2016-04-21
Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors
Grant 9,309,242 - Berdini , et al. April 12, 2
2016-04-12
Naphthyridine derivative compounds
Grant 9,309,241 - Angibaud , et al. April 12, 2
2016-04-12
Compounds
Grant 9,303,030 - Angibaud , et al. April 5, 2
2016-04-05
Substituted quinoxalines as FGFR kinase inhibitors
Grant 9,303,029 - Woodhead , et al. April 5, 2
2016-04-05
Bicyclic Heterocycle Compounds And Their Uses In Therapy
App 20160083377 - BUCK; Ildiko Maria ;   et al.
2016-03-24
Substituted quinoxalines as FGFR kinase inhibitors
Grant 9,290,478 - Saxty , et al. March 22, 2
2016-03-22
Quinazolinone Derivatives Useful As Fgfr Kinase Modulators
App 20160075666 - ANGIBAUD; Patrick Rene ;   et al.
2016-03-17
Pyrazole derivatives as protein kinase modulators
Grant 9,283,226 - Berdini , et al. March 15, 2
2016-03-15
Substituted Quinoxalines As Fgfr Kinase Inhibitors
App 20160031856 - SAXTY; Gordon ;   et al.
2016-02-04
Bicyclic Heterocycle Compounds And Their Uses In Therapy
App 20150353537 - CHESSARI; Gianni ;   et al.
2015-12-10
Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo- [2,3-D]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof
Grant 9,193,732 - Calienni , et al. November 24, 2
2015-11-24
Pteridines As Fgfr Inhibitors
App 20150291589 - Saxty; Gordon ;   et al.
2015-10-15
Bicyclic Heterocycle Compounds And Their Uses In Therapy
App 20150291586 - WOOLFORD; Alison Jo-Anne ;   et al.
2015-10-15
Bicyclic heterocycle compounds and their uses in therapy
Grant 9,155,743 - Buck , et al. October 13, 2
2015-10-13
Pharmaceutical compounds
Grant 9,145,354 - Woodhead , et al. September 29, 2
2015-09-29
Bicyclic Heterocycle Compounds And Their Uses In Therapy
App 20150266873 - Chessari; Gianni ;   et al.
2015-09-24
Bicyclic Heterocycle Compounds And Their Uses In Therapy
App 20150259359 - Chessari; Gianni ;   et al.
2015-09-17
New Compounds
App 20150239883 - Angibaud; Patrick Rene ;   et al.
2015-08-27
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
Grant 9,051,278 - Berdini , et al. June 9, 2
2015-06-09
Bicyclic heterocycle compounds and their uses in therapy
Grant 9,018,214 - Woolford , et al. April 28, 2
2015-04-28
Pyrazolyl Quinoxaline Kinase Inhibitors
App 20150105368 - SAXTY; Gordon ;   et al.
2015-04-16
Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein
Grant 9,006,430 - Berdini , et al. April 14, 2
2015-04-14
New Compounds
App 20150057293 - Angibaud; Patrick Rene ;   et al.
2015-02-26
Pharmaceutical Compounds
App 20150051199 - Woodhead; Andrew James ;   et al.
2015-02-19
Hydroxybenzamide Derivatives And Their Use As Inhibitors Of HSP90
App 20150045362 - Chessari; Gianni ;   et al.
2015-02-12
Anticancer Benzopyrazines Via The Inhibition Of Fgfr Kinases
App 20150031669 - Woodhead; Steven John ;   et al.
2015-01-29
Pharmaceutical combinations
Grant 8,916,552 - Gallagher , et al. December 23, 2
2014-12-23
3,4-disubstituted 1h-pyrazole Compounds And Their Use As Cyclin Dependent Kinase And Glycogen Synthase Kinase-3 Modulators
App 20140371213 - BERDINI; Valerio ;   et al.
2014-12-18
Bicyclic heterocyclic compounds as FGFR inhibitors
Grant 8,895,745 - Berdini , et al. November 25, 2
2014-11-25
Pyrazolyl quinoxaline kinase inhibitors
Grant 8,895,601 - Saxty , et al. November 25, 2
2014-11-25
Pharmaceutical combinations
Grant 8,883,790 - Gallagher , et al. November 11, 2
2014-11-11
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
Grant 8,859,582 - Saxty , et al. October 14, 2
2014-10-14
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
Grant 8,859,583 - Saxty , et al. October 14, 2
2014-10-14
Ortho-condensed Pyridine And Pyrimidine Derivatives (e.g., Purines) As Protein Kinases Inhibitors
App 20140303177 - BERDINI; Valerio ;   et al.
2014-10-09
Quinolines As Fgfr Kinase Modulators
App 20140296236 - Berdini; Valerio ;   et al.
2014-10-02
Anticancer Pyridopyrazines Via The Inhibition Of Fgfr Kinases
App 20140288053 - Berdini; Valerio ;   et al.
2014-09-25
Substituted Benzylamine Compounds, Their Use In Medicine, And In Particular The Treatment Of Hepatitis C Virus (hcv) Infection
App 20140288040 - Woodhead; Andrew James ;   et al.
2014-09-25
Pyrazole Derivatives As Protein Kinase Modulators
App 20140271662 - BERDINI; Valerio ;   et al.
2014-09-18
Hydroxybenzamide derivatives and their use as inhibitors of Hsp90
Grant 8,816,087 - Chessari , et al. August 26, 2
2014-08-26
Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitors
Grant 8,809,336 - Berdini , et al. August 19, 2
2014-08-19
Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases
Grant 8,796,244 - Berdini , et al. August 5, 2
2014-08-05
Purine and deazapurine derivatives as pharmaceutical compounds
Grant 8,796,293 - Davies , et al. August 5, 2
2014-08-05
Pharmaceutical compounds
Grant 8,779,132 - Congreve , et al. July 15, 2
2014-07-15
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
Grant 8,779,147 - Berdini , et al. July 15, 2
2014-07-15
Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases
Grant 8,778,936 - Berdini , et al. July 15, 2
2014-07-15
Bicyclic Heterocycle Compounds And Their Uses In Therapy
App 20140179666 - Woolford; Alison Jo-Anne ;   et al.
2014-06-26
Pyrrolopyrimidine Compounds And Their Uses
App 20140135312 - BESONG; Gilbert ;   et al.
2014-05-15
Imidazo [1,2-A]pyridine derivatives as FGFR kinase inhibitors for use in therapy
Grant 8,722,687 - Saxty , et al. May 13, 2
2014-05-13
Ortho-Condensed Pyridine and Pyrimidine Derivatives (e.g., Purines) as Protein Kinases Inhibitors
App 20140107137 - BERDINI; Valerio ;   et al.
2014-04-17
Pyrazole derivatives as protein kinase modulators
Grant 8,691,806 - Berdini , et al. April 8, 2
2014-04-08
Pyrrolopyrimidine compounds and their uses
Grant 8,685,980 - Besong , et al. April 1, 2
2014-04-01
Pharmaceutical compounds
Grant 8,664,218 - Williams , et al. March 4, 2
2014-03-04
Hydrobenzamide derivatives as inhibitors of Hsp90
Grant 8,653,084 - Frederickson , et al. February 18, 2
2014-02-18
Bicyclic Heterocycle Compounds And Their Uses In Therapy
App 20140045831 - Buck; Ildiko Maria ;   et al.
2014-02-13
Benzimidazole Derivatives And Their Use As Protein Kinase Inhibitors
App 20140010892 - BERDINI; Valerio ;   et al.
2014-01-09
Imidazole derivatives and their use as modulators of cyclin dependent kinases
Grant 8,598,217 - Howard , et al. December 3, 2
2013-12-03
Substituted Benzopyrazin Derivatives As Fgfr Kinase Inhibitors For The Treatment Of Cancer Diseases
App 20130267525 - Saxty; Gordon ;   et al.
2013-10-10
Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitors
Grant 8,546,407 - Berdini , et al. October 1, 2
2013-10-01
Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators
Grant 8,541,461 - Thompson , et al. September 24, 2
2013-09-24
Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90
Grant 8,530,469 - Chessari , et al. September 10, 2
2013-09-10
Salt(s) Of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo- [2,3-d]pyrimidine-6-carboxylic Acid Dimethylamide And Processes Of Making Thereof
App 20130217698 - Calienni; John Vincent ;   et al.
2013-08-22
Imidazo[1,2-a]pyridine compounds for use in treating cancer
Grant 8,513,276 - Berdini , et al. August 20, 2
2013-08-20
Pharmaceutical Compounds
App 20130210820 - Williams; Brian John ;   et al.
2013-08-15
Compositions comprising (S)-2-amino-1-(4-chlorophenyl)-1-[4-(1H-pyrazol-4-yl)-phenyl]-ethanol as modulator of protein kinases
Grant 8,497,294 - Woodhead , et al. July 30, 2
2013-07-30
Bicyclic heterocyclyl derivatives as FGFR kinase inhibitors for therapeutic use
Grant 8,481,531 - Saxty , et al. July 9, 2
2013-07-09
Pharmaceutical combinations of 1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyra- zol-4-yl]-urea
Grant 8,435,970 - Curry , et al. May 7, 2
2013-05-07
Pyrrolopyrimidine compounds and their uses
Grant 8,415,355 - Brain , et al. April 9, 2
2013-04-09
Combinations of pyrazole kinase inhibitors
Grant 8,404,718 - Curry , et al. March 26, 2
2013-03-26
Pyrazolyl Quinazoline Kinase Inhibitors
App 20130072457 - Saxty; Gordon ;   et al.
2013-03-21
Pharmaceutical compounds
Grant 8,399,442 - Berdini , et al. March 19, 2
2013-03-19
Pharmaceutical compounds
Grant 8,383,619 - Williams , et al. February 26, 2
2013-02-26
Pyrazole derivatives
Grant 8,367,687 - Brain , et al. February 5, 2
2013-02-05
Pyrazole Derivatives As Protein Kinase Modulators
App 20130005702 - BERDINI; Valerio ;   et al.
2013-01-03
Pharmaceutical compounds
Grant 8,343,953 - Davies , et al. January 1, 2
2013-01-01
Pyrrolopyrimidine compounds and their uses
Grant 8,324,225 - Brain , et al. December 4, 2
2012-12-04
4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
Grant 8,293,767 - Wyatt , et al. October 23, 2
2012-10-23
Pharmaceutical combinations
Grant 8,277,807 - Gallagher , et al. October 2, 2
2012-10-02
3,4-disubstituted 1h-pyrazole Compounds And Their Use As Cyclin Dependent Kinase And Glycogen Synthase Kinase-3 Modulators
App 20120213791 - BERDINI; Valerio ;   et al.
2012-08-23
Pyrazole derivatives as protein kinase modulators
Grant 8,247,576 - Berdini , et al. August 21, 2
2012-08-21
Imidazopyridine Derivatives As Inhibitors Of Receptor Tyrosine Kinases
App 20120208791 - Berdini; Valerio ;   et al.
2012-08-16
Pyrrolopyrimidine Compounds And Their Uses
App 20120207763 - BRAIN; Christopher Thomas ;   et al.
2012-08-16
Pyrazole Compounds That Modulate The Activity Of Cdk, Gsk And Aurora Kinases
App 20120190673 - BERDINI; Valerio ;   et al.
2012-07-26
Imidazole Derivatives And Their Use As Modulators Of Cyclin Dependent Kinases
App 20120101064 - Howard; Steven ;   et al.
2012-04-26
FGFR pharmacophore compounds
Grant 8,131,527 - Saxty , et al. March 6, 2
2012-03-06
Imidazo [1,2-a]pyridine Derivatives As Fgfr Kinase Inhibitors For Use In Therapy
App 20120041000 - Saxty; Gordon ;   et al.
2012-02-16
Bicyclic Heterocyclic Compounds As Protein Tyrosine Kinase Inhibitors
App 20120035153 - SAXTY; Gordon ;   et al.
2012-02-09
Bicyclic Heterocyclyl Derivatives As Fgfr Kinase Inhibitors For Therapeutic Use
App 20120035171 - Saxty; Gordon ;   et al.
2012-02-09
Bicyclic Heterocyclic Compounds As Protein Tyrosine Kinase Inhibitors
App 20120035152 - SAXTY; Gordon ;   et al.
2012-02-09
Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases
Grant 8,110,573 - Berdini , et al. February 7, 2
2012-02-07
Dihydroxyphenyl isoindolylmethanones
Grant 8,106,057 - Chessari , et al. January 31, 2
2012-01-31
Hydroxybenzamide derivatives and their use as inhibitors of HSP90
Grant 8,101,648 - Chessari , et al. January 24, 2
2012-01-24
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
Grant 8,080,666 - Berdini , et al. December 20, 2
2011-12-20
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
Grant 8,076,354 - Saxty , et al. December 13, 2
2011-12-13
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
Grant 8,071,614 - Saxty , et al. December 6, 2
2011-12-06
4-(2,6-dichloro-benzoylamino)-1h-pyrazole-3-carboxylic Acid Piperidin-4-ylamide Acid Addition Salts As Kinase Inhibitors
App 20110274616 - WYATT; Paul Graham ;   et al.
2011-11-10
Compositions Comprising (s)-2-amino-1-(4-chlorophenyl)-1-[4-(1h-pyrazol-4-yl)-phenyl]-ethanol As Modulator Of Protein Kinases
App 20110269808 - WOODHEAD; Steven John ;   et al.
2011-11-03
Benzimidazole Derivatives And Their Use As Protein Kinase Inhibitors
App 20110224203 - BERDINI; Valerio ;   et al.
2011-09-15
4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
Grant 8,013,163 - Wyatt , et al. September 6, 2
2011-09-06
Benzimidazole derivatives and their use as protein kinase inhibitors
Grant 7,977,477 - Berdini , et al. July 12, 2
2011-07-12
Pharmaceutical Combinations
App 20110159111 - Curry; Jayne Elizabeth ;   et al.
2011-06-30
Pyrazole Derivatives As Protein Kinase Modulators
App 20110144080 - Berdini; Valerio ;   et al.
2011-06-16
Imidazo[4, 5-B]pyridin-2-one and oxazolo[4, 5-B] pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds
Grant 7,951,819 - Niculescu-Duvaz , et al. May 31, 2
2011-05-31
Pharmaceutical Combinations
App 20110105501 - Gallagher; Neil James ;   et al.
2011-05-05
Combinations of Pyrazole Kinase Inhibitors
App 20110002879 - CURRY; Jayne Elizabeth ;   et al.
2011-01-06
3,4-disubstituted 1h-pyrazole Compounds And Their Use As Cyclin Dependent Kinase And Glycogen Synthase Kinase-3 Modulators
App 20110003799 - BERDINI; Valerio ;   et al.
2011-01-06
Bicyclic Heterocyclic Compounds As Protein Tyrosine Kinase Inhibitors
App 20100331296 - Saxty; Gordon ;   et al.
2010-12-30
Compounds
Grant 7,855,213 - Arnold , et al. December 21, 2
2010-12-21
Bicyclic Heterocyclic Compounds As Protein Tyrosine Kinase Inhibitors
App 20100286113 - Saxty; Gordon ;   et al.
2010-11-11
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
Grant 7,825,140 - Berdini , et al. November 2, 2
2010-11-02
Aryl-Alkylamines And Heteroaryl-Alkylamines As Protein Kinase Inhibitors
App 20100210617 - Woodhead; Steven John ;   et al.
2010-08-19
Dihydroxyphenyl isoindolymethanones
Grant 7,754,725 - Chessari , et al. July 13, 2
2010-07-13
Pharmaceutical Combinations Comprising Pyrazole Derivatives As Protein Kinase Modulators
App 20100166699 - Thompson; Neil Thomas ;   et al.
2010-07-01
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
Grant 7,745,638 - Berdini , et al. June 29, 2
2010-06-29
Pyrazole Derivatives As That Modulate The Activity Of Cdk, Gsk And Aurora Kinases
App 20100160324 - Berdini; Valerio ;   et al.
2010-06-24
Pharmaceutical Compounds
App 20100152184 - Congreve; Miles Stuart ;   et al.
2010-06-17
Pharmaceutical Compounds
App 20100130464 - Davies; Thomas Glanmor ;   et al.
2010-05-27
Bicyclic Heterocyclic Compounds as FGFR Inhibitors
App 20100120761 - Berdini; Valerio ;   et al.
2010-05-13
Substituted Piperidines Containing A Heteroarylamide Or Heteroarylphenyl Moiety
App 20100120798 - Woodhead; Steven John ;   et al.
2010-05-13
Compositions Comprising (s)-2-amino-1-(4-chlorophenyl)-1-[4-(1h-pyrazol-4-yl)-phenyl]-ethanol As Modulator Of Protein Kinases
App 20100113551 - Woodhead; Steven John ;   et al.
2010-05-06
Hydroxybenzamide derivatives and their use as inhibitors of Hsp90
Grant 7,700,625 - Chessari , et al. April 20, 2
2010-04-20
Substituted Piperidines Having Protein Kinase Inhibiting Activity
App 20100093748 - Woodhead; Steven John ;   et al.
2010-04-15
Pharmaceutical Combinations Of 1-cyclopropyl-3- [3-(5-m0rphoolin-4-yl-methyl-1h-benzoimidazol-2-yl)- Lh-1-pyrazol-4-yl]- Urea
App 20100055094 - Curry; Jayne Elizabeth ;   et al.
2010-03-04
Combinations Of Pyrazole Derivatives For The Inhibition Of Cdks And Gsk's
App 20100021420 - Lyons; John Francis ;   et al.
2010-01-28
Purine And Deazapurine Derivatives As Pharmaceutical Compounds
App 20100022564 - Davies; Thomas Glanmor ;   et al.
2010-01-28
Pharmaceutical Compounds
App 20100016340 - Woodhead; Steven John ;   et al.
2010-01-21
Pharmaceutical Compounds
App 20100004232 - Berdini; Valerio ;   et al.
2010-01-07
Pharmaceutical Compounds
App 20100004243 - Congreve; Miles Stuart ;   et al.
2010-01-07
4-(2, 6-Dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl)-amide for the Treatment of Cancer
App 20090318500 - Trewartha; Gary ;   et al.
2009-12-24
Pyrrolopyrimidine Compounds and Their Uses
App 20090318441 - Brain; Christopher Thomas ;   et al.
2009-12-24
Medical Use Of Cyclin Dependent Kinases Inhibitors
App 20090318430 - Pike; Andrew ;   et al.
2009-12-24
Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds
Grant 7,625,922 - Niculescu-Duvaz , et al. December 1, 2
2009-12-01
Pharmaceutical Combinations
App 20090263398 - Lyons; John Francis ;   et al.
2009-10-22
Pharmaceutical Compounds
App 20090253718 - Davies; Thomas Glanmor ;   et al.
2009-10-08
Ortho-Condensed Pyridine and Pyrimidine Derivatives (e.g., Purines) as Protein Kinases Inhibitors
App 20090247538 - Berdini; Valerio ;   et al.
2009-10-01
New Compounds 835
App 20090233943 - Burrows; Jeremy Nicholas ;   et al.
2009-09-17
Hydroxybenzamide derivatives and their use as inhibitors of HSP90
App 20090215772 - Chessari; Gianni ;   et al.
2009-08-27
Pyrimidine Derivatives As HSP90 Inhibitors
App 20090215777 - Chessari; Gianni ;   et al.
2009-08-27
Pharmaceutical Combinations of Diazole Derivatives for Cancer Treatment
App 20090142337 - Squires; Matthew Simon
2009-06-04
2-Aminopyrimidin-4-Ones And Their Use For Treating Or Preventing Alpha Beta-Related Pathologies
App 20090099217 - Berg; Stefan ;   et al.
2009-04-16
Ortho-Condensed Pyridine and Pyrimidine Derivatives (e.g., Purines) as Protein Kinases Inhibitors
App 20090099213 - Berdini; Valerio ;   et al.
2009-04-16
Pharmaceutical Compounds
App 20090036435 - Curry; Jayne Elizabeth ;   et al.
2009-02-05
4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
App 20090012124 - Wyatt; Paul Graham ;   et al.
2009-01-08
Thiazole And Isothiazole Derivatives That Modulate The Activity Of CDK, GSK And Aurora Kinases
App 20080312223 - Berdini; Valerio ;   et al.
2008-12-18
Pyrazole Derivatives for the Inhibition of CDK'S and GSK'S
App 20080306069 - Wyatt; Paul Graham ;   et al.
2008-12-11
Pharmaceutical Compounds
App 20080306054 - Chessari; Gianni ;   et al.
2008-12-11
New Compounds 835
App 20080287460 - Burrows; Jeremy Nicholas ;   et al.
2008-11-20
Compounds for Treating Protein-Kinase Mediated Disorders
App 20080275029 - Berdini; Valerio ;   et al.
2008-11-06
3,4-disubstituted 1h-pyrazole Compounds And Their Use As Cyclin Dependent Kinase And Glycogen Synthase Kinase-3 Modulators
App 20080269207 - Berdini; Valerio ;   et al.
2008-10-30
3,4-disubstituted 1h-pyrazole Compounds And Their Use As Cyclin Dependent Kinase And Glycogen Synthase Kinase-3 Modulators
App 20080200509 - Berdini; Valerio ;   et al.
2008-08-21
Pyrazole Derivatives For The Inhibition Of Cdk's And Gsk's
App 20080194562 - Wyatt; Paul Graham ;   et al.
2008-08-14
Pharmaceutical Compounds
App 20080167309 - Berdini; Valerio ;   et al.
2008-07-10
Combinations of Pyrazole Kinase Inhibitors and Further Antitumor Agents
App 20080161355 - Curry; Jayne Elizabeth ;   et al.
2008-07-03
Pharmaceutical Compounds
App 20080161251 - Curry; Jayne Elizabeth ;   et al.
2008-07-03
Pyrazole Derivatives For The Inhibition Of Cdk's And Gsk's
App 20080139620 - Wyatt; Paul Graham ;   et al.
2008-06-12
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
Grant 7,385,059 - Berdini , et al. June 10, 2
2008-06-10
Pyrazole Compounds that Modulate the Activity of Cdk, Gsk and Aurora Kinases
App 20080132495 - Berdini; Valerio ;   et al.
2008-06-05
3,4-Disubstituted Pyrazoles as Cyclin Dependent Kinases (Cdk) or Aurora Kinase or Glycogen Synthase 3 (Gsk-3) Inhibitors
App 20080004270 - Gill; Adrian Liam ;   et al.
2008-01-03
Hydroxybenzamide Derivatives And Their Use As Inhibitors Of HSP90
App 20070276026 - Chessari; Gianni ;   et al.
2007-11-29
Crystal structure of cytochrome P450
Grant 7,148,046 - Williams December 12, 2
2006-12-12
Synthesis and screening of ligands using X-ray crystallography
Grant 7,149,280 - Jhoti , et al. December 12, 2
2006-12-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed